Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision label changed from `v3.7.0` to `v3.7.1` while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. The detailed trial information and related sections appear to be removed or hidden, leaving a simple error page with a Home link.SummaryDifference17%

- Check37 days agoChange DetectedThe page deletes the 'Schizophrenia' topic label and the 'related topics' section that includes a link to MedlinePlus Genetics. This changes how the study's subject and available related resources are presented on the page.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.6.6 was added and Revision: v3.6.5 was removed, indicating a minor version update on the page. This update likely reflects a backend or content adjustment rather than changes to the main content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe study record now shows termination due to business reasons. It also indicates that results have been posted.SummaryDifference3%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.